tiprankstipranks
TipRanksTop Financial ExpertsInsidersNoubar Afeyan

Noubar Afeyan Insider Profile

18 Followers
Noubar Afeyan, Director at Moderna, holds 6.86M shares in Moderna (Ticker: MRNA), holds ― shares in Rubius Therapeutics (Ticker: RUBY), holds ― shares in Evelo Biosciences (Ticker: EVLO).
See the Hottest Stocks Based on Insider Trading >
tipranks
Noubar Afeyan

Noubar Afeyan
Moderna (MRNA)
Director

Ranked #97,054 out of 109,030 Corporate Insiders

Profitable Transactions

75%
6 out of 8 Profitable Transactions

Average Return

-29.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$2B
47.96%
47.87%
4.17%
0.00%
0.00% Others
A breakdown of Noubar Afeyan's holdings
See the Top Stocks by Insiders

Insider Roles

Moderna
(MRNA)
Director
Generate Biomedicines, Inc.
(GENB)
Director, Ten Percent Owner
Seres Therapeutics
(MCRB)
Director, Ten Percent Owner
Evelo Biosciences
(EVLO)
Director, Ten Percent Owner
+3 other positions
Roles that Noubar Afeyan holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
BG Medicine
(BGMD)
Rating:Informative Sell
Date:Dec 11, 2015 - Dec 11, 2016
Return:+91.90%
The most profitable trade made by Noubar Afeyan
See the Latest Stocks Traded by Insiders

Noubar Afeyan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MRNA
Moderna
May 22, 2026
Director
Uninformative Buy
177.39K
$987.08M
RUBY
Rubius Therapeutics
―
―
―
―
EVLO
Evelo Biosciences
―
Director, Ten Percent Owner
―
―
OMGAQ
Omega Therapeutics
―
―
―
―
GENB
Generate Biomedicines, Inc.
Mar 02, 2026
Director, Ten Percent Owner
Uninformative Buy
―
$985.22M
BGMD
BG Medicine
Dec 11, 2015
Director, Ten Percent Owner
Informative Sell
26.01K
―
MCRB
Seres Therapeutics
Jun 20, 2019
Director, Ten Percent Owner
Informative Buy
20.00M
$85.88M
BINDQ
DNIB Unwind, Inc.
Sep 27, 2013
―
Informative Buy
300.00K
$226.58K
AGEN
Agenus
―
Director
―
$0.00
CARM
Carisma Therapeutics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Noubar Afeyan's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Noubar Afeyan insider profile FAQ

What is the percentage of profitable transactions made by Noubar Afeyan?
The percentage of profitable transactions made by Noubar Afeyan is 75%.
    What is the average return per transaction made by Noubar Afeyan?
    The average return per transaction made by Noubar Afeyan is -29.00%.
      What stocks does Noubar Afeyan hold?
      Noubar Afeyan holds: MRNA, RUBY, EVLO, OMGAQ, GENB, BGMD, MCRB, BINDQ, AGEN, CARM stocks.
        What was Noubar Afeyan’s latest transaction?
        Noubar Afeyan latest transaction was an Uninformative Buy of $177.39K.
          What was Noubar Afeyan's most profitable transaction?
          Noubar Afeyan’s most profitable transaction was an Informative Sell of BGMD stock on December 11, 2015. The return on the trade was 91.90%.
            What is Noubar Afeyan's role in Moderna?
            Noubar Afeyan's role in Moderna is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.